Enoxaparin Sodium
Summary of product characteristics
Effective Time
20221105
Version
2
Spl Product Data Elements
Enoxaparin Sodium Enoxaparin Sodium ENOXAPARIN SODIUM ENOXAPARIN WATER Enoxaparin Sodium Enoxaparin Sodium ENOXAPARIN SODIUM ENOXAPARIN WATER Enoxaparin Sodium Enoxaparin Sodium ENOXAPARIN SODIUM ENOXAPARIN WATER Enoxaparin Sodium Enoxaparin Sodium ENOXAPARIN SODIUM ENOXAPARIN WATER Enoxaparin Sodium Enoxaparin Sodium ENOXAPARIN SODIUM ENOXAPARIN WATER Enoxaparin Sodium Enoxaparin Sodium ENOXAPARIN SODIUM ENOXAPARIN WATER Enoxaparin Sodium Enoxaparin Sodium ENOXAPARIN SODIUM ENOXAPARIN WATER
Application Number
ANDA076726
Brand Name
Enoxaparin Sodium
Generic Name
Enoxaparin Sodium
Product Ndc
11797-760
Product Type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS,SUBCUTANEOUS
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 11797-757-06 Enoxaparin Sodium Injection USP 30 mg/0.3 mL SINGLE-DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 0.3 mL Syringes NDC 11797-758-06 Enoxaparin Sodium Injection USP 40 mg/0.4 mL SINGLE-DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 0.4 mL Syringes NDC 11797-759-06 Enoxaparin Sodium Injection USP 60 mg/0.6 mL SINGLE-DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 0.6 mL Syringes NDC 11797-760-06 Enoxaparin Sodium Injection USP 80 mg/0.8 mL SINGLE-DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 0.8 mL Syringes NDC 11797-761-06 Enoxaparin Sodium Injection USP 100 mg/1 mL SINGLE-DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 1 mL Syringes NDC 11797-762-06 Enoxaparin Sodium Injection USP 120 mg/0.8 mL SINGLE-DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 0.8 mL Syringes NDC 11797-763-06 Enoxaparin Sodium Injection USP 150 mg/1 mL SINGLE-DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 1 mL Syringes 30 mg 40 mg 60 mg 80 mg 100 mg 120 mg 150 mg
150 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.